Virus Filtration Market to have 13% of CAGR Growth by 2025 - Thermo Fisher Scientific, Danaher, General Electric, Lonza, Charles River, Asahi Kasei Medical, Wuxi AppTec

2018-2025 Virus Filtration Market - Global Status and Outlook

The objective of the study is to describe, define, and forecast the virus filtration market by product, application, end user, and region. The report also provide detailed information regarding the major factors influencing growth of the market (drivers, restraints, opportunities, and trends). The report helps to analyze market with respect to individual growth trends, prospects, and contributions to the overall virus filtration market.

Virus filtration is a robust and effective virus clearance technology that is common unit operation in the manufacture of biologics. Some biological therapeutic products are produced using mammalian cell lines or human plasma. The risk of contamination with either known or unknown viruses in these products has been demonstrated; hence, regulatory agencies have mandated that manufacturers evaluate the risks of virus contamination and take necessary measures to mitigate these risks.

Get Sample Copy at http://bit.ly/2UcOCC0

The report analyzes factors affecting market from both demand and supply side and further evaluates virus filtration market dynamics effecting the virus filtration market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions. The report also includes the profiles of key manufacturing companies along with their SWOT analysis and market strategies.

Major Players operating in the Virus Filtration Market-
1. Merck KGaA
2. Sartorius AG
3. Danaher (Pall Corporation)
4. Thermo Fisher Scientific, Inc.
5. General Electric
6. Charles River
7. Wuxi Apptec
8. Lonza
9. Asahi Kesai Corporation
10. Clean Cells

Market Developments-
The company players are indulged into development of novel and innovative products to cater the demands of users in the virus filtration market. For instance, in June 2016, Sartorius Stedim Biotech (SSB), a sub-division of Sartorius AG introduced a new virus-retentive filter to be used in the cell culture media. The new filter provides the highest level of safety for customers’ upstream processes. This launch is expected to compliment and increase the bioprocess portfolio of Sartorius.

Have Queries? Ask us at http://bit.ly/2U7wbhP

Key factors driving the market are rapid growth of pharmaceutical and biotechnology industry, increasing investments in R&D and outsourcing activities are key drivers for the growth of the market. The report would be of an interest to various stakeholders operating in the virus filtration market. These stakeholders include healthcare institutes, contract research organizations (CROs), research institutes, virus filtration product manufacturers and vendors, research consulting firms, virus filtration service providers, distributors and others.

Virus filtration market is segmented into product, application, and end user. On the basis of product, the market is segmented into filtration systems, kits & reagents, services and others. The market based on the application is segmented into biologics, medical devices, water purification, and air purification. On the basis of end user, the global virus filtration market is segmented into pharmaceutical & biotechnology companies, contract research organizations, medical device companies, and academic research institutes.

Regulatory authorities such as Food & Drug Administration, European Medicine Agency (EMA) and others has consistently shown a tough stance towards pharmaceutical can biotechnology manufacturers. The industry players are compiled to maintain their awareness and abide by the updated regulations pertaining to current good manufacturing practices (cGMP) as well as good laboratory practices (GLP) to assure proper design, monitoring, and control of manufacturing processes and facilities. The US Food and Drug Administration released a document of guidelines and requirements for biotechnology and pharmaceutical manufacturers in 1998 that intends on virus safety evaluation of biotechnology and pharmaceutical products that are derived from cell lines of human or animal origin. The stringent regulations enforced by healthcare governing bodies to perform virus clearance tests during the drug development procedures is expected to increase the demand of virus filtration market not only in the pharmaceutical sectors but also in the medical device manufacturing capabilities that uses mammalian derived cell lines. Moreover, the streamlining regulatory framework in the emerging markets such as India to realign the quality of the manufacturing process is further expected to propel the market growth.

Buy this Report now at http://bit.ly/2U842HD

About Us - The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services.

Contact us -
Contact Person : Sameer Joshi
Phone : +1-646-491-9876
Email Id : sam@theinsightpartners.com

This release was published on openPR.